Moreover, it has been reported by Dmitrieva-Posocco et al. that the ketone body β-Hydroxybutyrate (BHB) suppresses colorectal cancer (CRC) progression by inducing HOPX [51]. Here, HOPX is linked to colorectal carcinoma.